Two cases in which eribulin mesylate was effective for taxane-resistant advanced breast cancer

Keita Adachi, Shuhei Suzuki, Hitomi Kubota, Yukiko Hara, Asako Fujiwara, Eiko Waga, Tomohiro Hirano, Katsuhisa Enomoto, Kenichi Sakurai, Makoto Makishima, Tsugumichi Koshinaga

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Two cases in which eribulin mesylate was effective for taxane-resistant advanced breast cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry